Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
An early British case of neuromyelitis optica (1850).
Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
Natalizumab therapy for multiple sclerosis.
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
Nurr1 reduction influences the onset of chronic EAE in mice.
Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.
Alemtuzumab in multiple sclerosis: an update.
Immune surveillance and response to JC virus infection and PML.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.
A Psychometric Validation of Two Brief Measures to Assess Palliative Need in Patients Severely Affected by Multiple Sclerosis.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Tropical myelopathies.
Natalizumab: Bench to Bedside and Beyond.
Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.
Nonlinear dynamical structure of sway path during standing in patients with multiple sclerosis and in healthy controls is affected by changes in sensory input and cognitive load.
Obesity and HLA in multiple sclerosis: Weighty matters.
Pages
« first
‹ previous
…
387
388
389
390
391
392
393
394
395
…
next ›
last »